Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease Reply

被引:3
|
作者
Casella, James F. [1 ]
Kronsberg, Shari S. [2 ]
Gorney, Rebecca T. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
来源
关键词
D O I
10.1001/jama.2021.11103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:975 / 976
页数:2
相关论文
共 50 条
  • [41] Lower Airway Obstruction Is Associated with Increased Vaso-Occlusive Pain Episodes in Adults with Sickle Cell Anemia
    Ivy, Zalaya K.
    Kassim, Adetola A.
    Payne, Amanda B.
    Macklin, Eric A.
    Rodeghier, Mark J.
    Strunk, Robert C.
    DeBaun, Michael R.
    [J]. BLOOD, 2015, 126 (23)
  • [42] Tinzaparine in the management of painful vaso-occlusive crisis of sickle cell anaemia.
    Qari, MH
    Mousa, S
    Alsaigh, MA
    Zografos, P
    Aljaouni, SK
    Fatani, H
    Alalfi, A
    Alsayes, FM
    Beirouti, BT
    Alamin, MA
    Gadi, A
    [J]. BLOOD, 2005, 106 (11) : 658A - 658A
  • [43] Sickle Cell Disease and Pain Is it all Vaso-occlusive Crises?
    Ramsay, Zachary
    Bartlett, Rachel
    Ali, Amza
    Grant, Justin
    Gordon-Strachan, Georgiana
    Asnani, Monika
    [J]. CLINICAL JOURNAL OF PAIN, 2021, 37 (08): : 583 - 590
  • [44] Upper airway microbiome changes in children with sickle cell disease during vaso-occlusive and acute chest syndrome episodes
    Loman, Brett R.
    Shrestha, Chandra L.
    Kotha, Kavitha
    Minta, Abena
    Zhang, Shuzhong
    Mejias, Asuncion
    Bailey, Michael T.
    Creary, Susan
    Kopp, Benjamin T.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : E289 - E292
  • [45] Crizanlizumab in vaso-occlusive crisis caused by sickle cell disease
    Gardner, R., V
    [J]. DRUGS OF TODAY, 2020, 56 (11) : 705 - 714
  • [46] Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease
    Weaver, Salome Bwayo
    Rungkitwattanakul, Dhakrit
    Singh, Divita
    [J]. JOURNAL OF PHARMACY PRACTICE, 2023, 36 (01) : 139 - 148
  • [47] Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
    Heeney, Matthew M.
    Abboud, Miguel R.
    Githanga, Jessie
    Inusa, Baba P. D.
    Kanter, Julie
    Michelson, Alan D.
    Nduba, Videlis
    Musiime, Victor
    Apte, Mohini
    Inati, Adlette
    Taksande, Amar M.
    Andersson, Marielle
    astrand, Magnus
    Maklad, Noha
    Niazi, Mohammad
    Himmelmann, Anders
    Berggren, Anders R.
    [J]. BLOOD, 2022, 140 (13) : 1470 - 1481
  • [48] Sensitization to Acute Procedural Pain in Pediatric Sickle Cell Disease: Modulation by Painful Vaso-Occlusive Episodes, Age, and Endothelin-1
    Schlenz, Alyssa M.
    McClellan, Catherine B.
    Mark, Teresa R. M.
    McKelvy, Alvin D.
    Puffer, Eve
    Roberts, Carla W.
    Sweitzer, Sarah M.
    Schatz, Jeffrey C.
    [J]. JOURNAL OF PAIN, 2012, 13 (07): : 656 - 665
  • [49] Antibiotics to modify sickle cell disease vaso-occlusive crisis?
    Stewart, Connor
    Jang, Tim
    Mo, George
    Mohamed, Nader
    Poplawska, Maria
    Egini, Ogechukwu
    Dutta, Dibyendu
    Lim, Seah H.
    [J]. BLOOD REVIEWS, 2021, 50
  • [50] Haptoglobin genotype predicts severe acute vaso-occlusive pain episodes in children with sickle cell anemia
    Willen, Shaina M.
    McNeil, Joel Brennan
    Rodeghier, Mark
    Kerchberger, Vern Eric
    Shaver, Ciara M.
    Bastarache, Julie A.
    Steinberg, Martin H.
    DeBaun, Michael R.
    Ware, Lorraine B.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (04) : E92 - E95